Recombinant activated protein C attenuates coagulopathy and inflammation when administered early in murine pneumococcal pneumonia

Recombinant human activated protein C (APC), which has both anticoagulant and anti-inflammatory properties, improves survival of patients with severe sepsis. This beneficial effect is especially apparent in patients with pneumococcal pneumonia. Earlier treatment with APC in sepsis has been associate...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Thrombosis and haemostasis Ročník 106; číslo 6; s. 1189
Hlavní autoři:	Schouten, Marcel, van 't Veer, Cornelis, Roelofs, Joris J T H, Gerlitz, Bruce, Grinnell, Brian W, Levi, Marcel, van der Poll, Tom
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Germany 01.12.2011
Témata:	Animals Anti-Inflammatory Agents - administration & dosage Antithrombin III - metabolism Biomarkers - metabolism Blood Coagulation - drug effects Cytokines - metabolism Disease Models, Animal Down-Regulation Fibrin Fibrinogen Degradation Products - metabolism Humans Lung - drug effects Lung - metabolism Lung - pathology Male Mice Mice, Inbred C57BL Peptide Hydrolases - metabolism Pneumonia, Pneumococcal - blood Pneumonia, Pneumococcal - immunology Protein C - administration & dosage Recombinant Proteins - administration & dosage Streptococcus pneumoniae - growth & development Streptococcus pneumoniae - immunology Streptococcus pneumoniae - pathogenicity
ISSN:	0340-6245, 2567-689X, 2567-689X
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!